(Q41366506)

30 September 2017

title

Defibrotide protects endothelial cells, but not L929 tumour cells, from tumour necrosis factor-alpha-mediated cytotoxicity (English)

1 reference

30 September 2017

Defibrotide Protects Endothelial Cells, but not L929 Tumour Cells, from Tumour Necrosis Factor-α-mediated Cytotoxicity (English)

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

8 June 2024

0 references

H. Schröder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7602491

8 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7602491

8 June 2024

publication date

1 March 1995

1 reference

full work available at URL

30 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-7158.1995.tb05789.x

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

http://academic.oup.com/jpp/article-pdf/47/3/250/36998414/j.2042-7158.1995.tb05789.x.pdf

8 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

Journal of Pharmacy and Pharmacology

8 June 2024

published in

1 reference

30 September 2017

volume

47

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

250-252

1 reference

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

Comparison of in vitro cell cytotoxic assays for tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

Tumor necrosis factor (TNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

A novel insight into the mechanism of the antithrombotic action of defibrotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1995.TB05789.X

Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells

8 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

Favourable effect of defibrotide in lipid A-induced shock in pigs

8 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

Nitric oxide but not prostacyclin is an autocrine endothelial mediator

8 June 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.2042-7158.1995.TB05789.X

8 June 2024

Identifiers

1 reference

release_cadceg34kzbbhl6vyhvoo72lz4

30 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cadceg34kzbbhl6vyhvoo72lz4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference